微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 46.47% | -3.63% | -2.69% | 10/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 47.75% | 2.09% | -8.62% | 7/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 52.26% | 6.75% | 6.56% | 7/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 49.04% | 22.85% | 1.71% | 9/51 | 38.12% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 48.21% | 16.1% | 3.08% | 13/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 46.77% | 12.55% | -4.44% | 13/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 48.95% | 6.13% | 22.62% | 8/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 39.92% | -0.3% | -3.88% | 30/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 41.53% | 9.57% | -0.08% | 27/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 41.56% | 13.27% | -9.89% | 26/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 46.12% | 2.4% | 15.19% | 18/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 40.04% | 124.72% | 5.64% | 31/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 37.9% | 184.55% | 3.3% | 27/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 36.69% | 186.95% | -18.54% | 33/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 45.04% | -8.54% | 127.81% | 15/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | -161.95% | -434.02% | -261.3% | 50/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | -44.83% | -182% | -450.56% | 34/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 12.79% | -77.69% | -74.04% | 36/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 49.25% | -15% | 1.57% | 7/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 48.49% | 7.98% | -11.3% | 14/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 54.66% | 54.61% | -4.61% | 7/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 57.31% | 35.26% | -1.09% | 8/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 57.94% | 25.56% | 29.04% | 6/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 44.9% | 56.7% | 27% | 17/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 35.36% | -6.78% | -16.55% | 20/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 42.37% | 38.48% | -8.19% | 20/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 46.14% | 98.73% | 61.03% | 13/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 28.66% | 533.29% | -24.45% | 36/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 37.93% | 1016.51% | 23.97% | 19/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 30.59% | 240.48% | 31.76% | 26/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 23.22% | 190.85% | 413.16% | 18/51 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 4.52% | 157.48% | 209.34% | 32/51 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | -4.14% | -1088.46% | 81% | 21/51 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | -21.78% | -1352.43% | 14.79% | 24/51 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | -25.56% | -952.97% | -224.66% | 20/51 | 28.42% | 盈康生命 | 75.69% | 行业排名> |
| 2015-12-31 | -7.87% | -280.15% | -2160.83% | 30/51 | 37.17% | 海特生物 | 95.38% | 行业排名> |
| 2015-09-30 | -0.35% | -104.17% | 76.78% | 21/51 | 33.25% | 药石科技 | 67.7% | 行业排名> |
| 2015-06-30 | -1.5% | -108.58% | -150.04% | 21/51 | 32.07% | 药石科技 | 66.33% | 行业排名> |
| 2015-03-31 | 3% | -90.51% | -31.43% | 18/51 | 24.2% | 睿智医药 | 52.68% | 行业排名> |